What Fueled The Previous Growth In The Oral Cancer Treatment Market?
The oral cancer treatment market has seen considerable growth due to a variety of factors.
• In the past few years, the oral cancer treatment market has experienced robust growth. The market, projected to rise from $2.04 billion in 2024 to $2.2 billion in 2025, will yield a compound annual growth rate (CAGR) of 7.4%.
Factors such as interdisciplinary treatment methodologies, implementation of screening programs, advancements in palliative care, innovations in reconstructive surgery, and the findings of clinical trials account for the significant growth during the historic period.
What Can Be Expected from the Oral Cancer Treatment Market Size?
The oral cancer treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of oral cancer treatment is projected to witness robust expansion in the coming years, with an estimated value of $2.86 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 6.9%.
The expected growth during the proposed period is due to regulatory endorsement of innovative therapy practices, advances in the area of biomarker research, broadening of treatment alternatives, enhanced screening methods and early detection, coupled with telemedicine and remote monitoring facilities. Key trends for the future include shifts in global disease patterns, regulatory modifications and approvals, increased awareness through early detection drives, patient-focused care, and supplementary therapies.
What Are the Critical Driver Fuelling The Oral Cancer Treatment Market's Growth?
The rising use of tobacco, which is anticipated to fuel the oral cancer treatment market's growth over time. Tobacco consists of the leaves of Nicotiana tabacum and other plants in the Nicotiana genus. Toxic substances, carcinogens, and nicotine found in tobacco products have been linked to an elevated risk of specific cancers, including oral cancer. For example, the UK's National Health Service reported in December 2023 that hospital admissions due to smoking had risen to an estimated 408,700 in 2022–23 from 389,800 in 2021–22, a 4.8% increase. Consequently, the rising tobacco usage is contributing to the growth of the oral cancer treatment market. The escalating incidence rate of oral cancer is believed to drive the expansion of the oral cancer treatment market in future. Oral cancer is a fatal neoplasm impacting the oral cavity's tissues, identified by unruly cell growth and invasion. The treatment for oral cancer usually consists of surgical resection, radiation therapy, and chemotherapy, depending on the disease's stage and extent. For example, the American Cancer Society, a US-based government organization, stated in 2022 that around 54,540 new cases of oral cavity or oropharyngeal cancer are diagnosed annually, leading to approximately 11,580 deaths from this same type of cancer. Thus, the growing incidence rate of oral cancer is spearheading the growth of the oral cancer treatment market.
How Is The Oral Cancer Treatment Market segmented?
The oral cancer treatment market covered in this report is segmented –
1) By Type: Oral Squamous Cell Carcinoma, Oral Verrucous Carcinoma, Mucoepidermoid Carcinoma, Oral Cavity Lymphomas
2) By Therapy Type: Chemotherapy, Radiation Therapy, Biological Therapy
3) By Route Of Administration: Oral, Injectable, Other Routes Of Administration
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Oral Squamous Cell Carcinoma: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy
2) By Oral Verrucous Carcinoma: Surgical Excision, Radiation Therapy
3) By Mucoepidermoid Carcinoma: Surgical Resection, Radiation Therapy, Chemotherapy
4) By Oral Cavity Lymphomas: Chemotherapy, Radiation Therapy, Immunotherapy
Pre-Book The Oral Cancer Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Oral Cancer Treatment Market?
Leading businesses in the oral cancer treatment market are pioneering novel treatments like CancerDetect to enhance their market profitability. CancerDetect is a diagnostic test for oral and throat cancer. For example, in August 2022, a US-based biotech firm, Viome Life Sciences Inc., initiated a treatment test known as CancerDetect. This is an early-detection test for oral and throat cancer biomarkers which can be carried out at home. The purpose of the CancerDetect test is to assist in identifying the molecular features associated with oral and throat cancers, specifically oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC).
Who Are the Key Players In The Oral Cancer Treatment Market?
Major companies operating in the oral cancer treatment market report are:
• Pfizer Inc.
• F. Hoffmann La Roche Ltd.
• Merck & Co.
• AbbVie Inc.
• Novartis AG
• Bayer AG
• Sanofi-Aventis LLC
• Bristol Myers Squibb
• AstraZeneca PLC
• GlaxoSmithKline PLC
• Eli Lilly and Company
• C.H. Boehringer Sohn AG & Co. KG.
• Viatris Inc.
• Teva Pharmaceuticals Industries Ltd.
• MD Anderson Cancer Center
• Bausch Health Companies Inc.
• Memorial Sloan Kettering Cancer Center
• Aurobindo Pharma Limited
• Cipla Inc.
• Sun Pharmaceutical Industries Ltd.
• Lupin Limited
• Fred Hutchinson Cancer Research Center
• Fresenius Kabi AG
• Innovent Biologics Inc.
• Genentech Inc.
• Intas Pharmaceuticals Ltd.
• Ascendis Pharma A/S
• Qilu Pharmaceutical Co. Ltd.
What Is The Most Dominant Region In The Oral Cancer Treatment Market?
North America was the largest region in the oral cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
